Evidence map›Paper›PMID 28786017›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2017

Standardization of health outcomes assessment for depression and anxiety: recommendations from the ICHOM Depression and Anxiety Working Group.

Alexander Obbarius, Lisa van Maasakkers, Lee Baer, David M Clark, Anne G Crocker, Edwin de Beurs, Paul M G Emmelkamp, Toshi A Furukawa, Erik Hedman-Lagerlöf, Maria Kangas and 14 more

Abstract read
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Anxiety and peripheral artery disease.Clinical science (London, England : 1979) · 2026
    Review
  11. Review
  12. Article
  13. Core Variables Sets: Beyond Outcome Measures.Psychotherapy and psychosomatics · 2026
    Article
  14. [Assessment of patient-reported outcomes as an instrument for patient-centered care?]Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Alexander ObbariusDepartment of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany. alexander.obbarius@charite.de.ORCID 0000-0003-2348-1348
Lisa van MaasakkersInternational Consortium for Health Outcomes Measurement (ICHOM), 14 Arrow St., Ste. #11, Cambridge, MA, 02138, USA.
Lee BaerHarvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.
David M ClarkDepartment of Experimental Psychology, University of Oxford, Tinbergen Building, South Parks Road, Oxford, OX1 3UD, UK.
Anne G CrockerInstitut Philippe-Pinel de Montréal, 10905 Henri-Bourassa Est, Montréal, QC, H1C 1H1, Canada.
Edwin de BeursStichting Benchmark GGZ, Rembrandtlaan 46, 3723 BK, Bilthoven, The Netherlands.
Paul M G EmmelkampNetherlands Institute for Advanced Study, Meijboomlaan 1, 2242 PR, Wassenaar, The Netherlands.
Toshi A FurukawaSchool of Public Health, Kyoto University Graduate School of Medicine, Yoshida Konoecho, Sakyo-ku, Kyoto, 606-8501, Japan.
Erik Hedman-LagerlöfDepartment of Clinical Neuroscience, Karolinska Institutet, Nobels väg 9, 17177, Stockholm, Sweden.
Maria KangasCentre for Emotional Health, Department of Psychology, Macquarie University, Building C3A, Level 7, Sydney, NSW, 2109, Australia.
Lucie Langford, Ottawa, ON, Canada.
Alain LesageDepartment of Psychiatry, University of Montréal, Pavillon Roger-Gaudry, C.P., 6128 succursale Centre-ville, Montréal, QC, H3C 3J, Canada.
Doris M MwesigireMakerere College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.
Sandra NolteDepartment of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Vikram PatelDepartment of Global Health and Social Medicine, Harvard Medical School, 641 Huntington Avenue, Boston, 02115, MA, USA.
Paul A PilkonisDepartment of Psychiatry, University of Pittsburgh School of Medicine, Thomas Detre Hall, 3811 O'Hara Street, Pittsburgh, PA, 15213, USA.
Harold A PincusDepartment of Psychiatry, Columbia University, New York Presbyterian Hospital, 630 West 168th Street, New York, NY, 10032, USA.
Roberta A ReisFederal University of Rio Grande do Sul, Grupo CNPq - GPEMSA - USP/São Paulo, Av. Paulo Gama, 110 - Bairro Farroupilha, Porto Alegre, Rio Grande do Sul, Brazil.
Graciela RojasClinical Hospital, Department of Psychiatry and Mental Health, University of Chile, Av. Libertador Bernardo O'Higgins 1058, Santiago de Chile, Chile.
Cathy SherbourneThe RAND Corporation, 1776 Main Street, Santa Monica, CA, 90407-2138, USA.
Dave SmithsonAnxiety UK, Zion Community Centre, 339 Stretford Road, Hulme, Manchester, M15 4ZY, UK.
Caleb StowellInternational Consortium for Health Outcomes Measurement (ICHOM), 14 Arrow St., Ste. #11, Cambridge, MA, 02138, USA.
Kelly Woolaway-BickelOffice of the U.S. Army Surgeon General, 7700 Arlington Blvd., Room 3SW116A, Falls Church, VA, 22042, USA.
Matthias RoseDepartment of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNational initiatives, such as the UK Improving Access to Psychological Therapies program (IAPT), demonstrate the feasibility of conducting empirical mental health assessments on a large scale, and similar initiatives exist in other countries. However, there is a lack of international consensus on which outcome domains are most salient to monitor treatment progress and how they should be measured. The aim of this project was to propose (1) an essential set of outcome domains relevant across countries and cultures, (2) a set of easily accessible patient-reported instruments, and (3) a psychometric approach to make scores from different instruments comparable.

methodsTwenty-four experts, including ten health outcomes researchers, ten clinical experts from all continents, two patient advocates, and two ICHOM coordinators worked for seven months in a consensus building exercise to develop recommendations based on existing evidence using a structured consensus-driven modified Delphi technique.

resultsThe group proposes to combine an assessment of potential outcome predictors at baseline (47 items: demographics, functional, clinical status, etc.), with repeated assessments of disease-specific symptoms during the treatment process (19 items: symptoms, side effects, etc.), and a comprehensive annual assessment of broader treatment outcomes (45 items: remission, absenteeism, etc.). Further, it is suggested reporting disease-specific symptoms for depression and anxiety on a standardized metric to increase comparability with other legacy instruments. All recommended instruments are provided online ( www.ichom.org ).

conclusionAn international standard of health outcomes assessment has the potential to improve clinical decision making, enhance health care for the benefit of patients, and facilitate scientific knowledge.

Indexed as

Sickness Impact ProfileAnxietyDepressionHumansPsychometricsTreatment OutcomeAnxietyDepressionHealth-related quality of lifeOutcome SetPatient-reported outcomesStandardization

Identifiers

PMID28786017
PMCPMC5681977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.